Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Miami
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Orca Biosystems, Inc.
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Manitoba
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Colorado, Denver
Washington University School of Medicine
Hoosier Cancer Research Network
Beijing 302 Hospital
Chinese PLA General Hospital
Masonic Cancer Center, University of Minnesota
Chinese PLA General Hospital
First People's Hospital of Hangzhou
H. Lee Moffitt Cancer Center and Research Institute
Second Affiliated Hospital, School of Medicine, Zhejiang University
National Cancer Institute (NCI)
Medical College of Wisconsin
Massachusetts General Hospital
Centre Hospitalier Universitaire de Nice
PETHEMA Foundation
Chinese PLA General Hospital
The First Affiliated Hospital of Soochow University
Dana-Farber Cancer Institute
The First Affiliated Hospital of Soochow University
The First Affiliated Hospital of Soochow University
The First Affiliated Hospital of Soochow University
Center for International Blood and Marrow Transplant Research
Center for International Blood and Marrow Transplant Research